MedPath

ATHEM, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

FDA:5

Drug Approvals

Pryidostigmine Bromide

Approval Date
Mar 23, 2023
FDA

Tolterodine Tartrate

Approval Date
Mar 23, 2023
FDA

Amantadine Hydrochloride

Approval Date
Mar 21, 2023
FDA

Timolol Maleate

Approval Date
Mar 8, 2022
FDA

Amantadine Hydrochloride

Approval Date
Feb 19, 2021
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.